{
    "2018-11-16": [
        [
            {
                "time": "2018-01-03",
                "original_text": "Top Stocks: IBD Screens Uncover Emerging Leaders Before Big Moves",
                "features": {
                    "keywords": [
                        "IBD Screens",
                        "Emerging Leaders",
                        "Big Moves"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "stocks"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-02-15",
                "original_text": "Interesting LLY Put And Call Options For February 2019",
                "features": {
                    "keywords": [
                        "LLY",
                        "Put",
                        "Call Options"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "Noteworthy ETF Outflows: SPYG, AMGN, TMO, LLY",
                "features": {
                    "keywords": [
                        "ETF Outflows",
                        "SPYG",
                        "AMGN",
                        "TMO",
                        "LLY"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "ETFs",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "Seattle Genetics' Adcetris Gets Breakthrough Therapy Status",
                "features": {
                    "keywords": [
                        "Seattle Genetics",
                        "Adcetris",
                        "Breakthrough Therapy"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-06",
                "original_text": "Gauging Analysts’ Views on Clovis Stock",
                "features": {
                    "keywords": [
                        "Analysts’ Views",
                        "Clovis Stock"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-07",
                "original_text": "Eli Lilly considers sale of off-patent drug assets in China - Bloomberg",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Sale",
                        "Off-patent Drug Assets",
                        "China"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-08",
                "original_text": "Pharma Stock Roundup: FDA Updates on MRK, AZN's Cancer Drugs, Bayer's Q3 Earnings",
                "features": {
                    "keywords": [
                        "FDA Updates",
                        "MRK",
                        "AZN",
                        "Cancer Drugs",
                        "Bayer",
                        "Q3 Earnings"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-09",
                "original_text": "Seattle Genetics' Adcetris Gets Breakthrough Therapy Status",
                "features": {
                    "keywords": [
                        "Seattle Genetics",
                        "Adcetris",
                        "Breakthrough Therapy"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-10",
                "original_text": "Eli Lilly Considers Sale of China Assets to Raise Cash",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Sale",
                        "China Assets",
                        "Raise Cash"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}